首页 > 最新文献

Indian Journal of Tuberculosis最新文献

英文 中文
Effect of adjunct Vitamin D treatment in vitamin D deficient pulmonary tuberculosis patients: A randomized, double blind, active controlled clinical trial 维生素D辅助治疗维生素D缺乏型肺结核患者的疗效:一项随机、双盲、主动对照的临床试验
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.ijtb.2023.04.026
Harish Chandra , Adil Rahman , Prashant Yadav , Geeta Maurya , Sushil Kumar Shukla

Background

Since, Vitamin D [1α,25(OH)2D)] enhances antimicrobial activity of Innate immunity and modulate Adaptive immune responses, simultaneously, so it play a potential role for balanced immune activity against Mycobacterium tuberculosis and restricting tissue injuries within the TB patients.(Chun et al., 2011) 9 We aimed to determine the role of adjunct Vitamin D treatment on the outcome of pulmonary tuberculosis patients and evaluated the effect of Vitamin D administration on Differential Leucocyte Count, Erythrocyte Sedimentation Rate, serum Adenosine deaminase, serum C- reactive protein, Oxygen saturation (SpO2) and Body Weight in Vitamin D deficient pulmonary tuberculosis patients.

Methods

We conducted a prospective, interventional, randomized, double blind, parallel group, active controlled clinical trial. Newly diagnosed Vitamin D deficient pulmonary tuberculosis patients were randomly assigned to intervention group (received standard anti-tubercular treatment with adjunct Vitamin D3) and control group (received standard anti-tubercular treatment without adjunct Vitamin D3). Total four doses [each dose of 2.5 mg (100000 IU)] of Vitamin D3 were given, orally. First dose was given within 7 days of starting anti-tubercular treatment and second, third, fourth dose were given at 2, 4 and 6 weeks respectively. At the time of enrollment, we measured all baseline characteristics. During follow-up, we measured the study variables and monitored adverse events at 2, 4, 6, 8 and 12 weeks. Our safety parameter was serum corrected calcium level to assess the risk of hypercalcemia.

Results

Total 130 pulmonary TB patients, 65 patients in each group, were analyzed. Our study results showed that decrease in Neutrophil count was statistically significant with small effect sizes at every time point of measurement and increase in Lymphocyte count was statistically significant with small and moderate effect sizes at 4, 6 and 8 week for intervention group than for control group. Decrease in erythrocyte sedimentation rate was statistically significant with small effect sizes at 6 and 8 week, decrease in serum adenosine deaminase and serum C- reactive protein was statistically significant with moderate effect sizes at 4, 6 and 8 week for intervention group than for control group. Increase in Oxygen saturation was statistically significant at 4 week with small effect size and increase in body weight was statistically significant with small effect sizes for intervention group than for control group. No case of hypercalcemia was reported.

Conclusion

Our findings suggest a potential role of adjunctive Vitamin D3 to accelerate resolution of inflammatory responses and improvement in clinical outcomes of pulmonary TB patients.

背景由于维生素 D [1α,25(OH)2D)]能同时增强先天性免疫的抗菌活性和调节适应性免疫反应,因此它在平衡结核分枝杆菌的免疫活性和限制结核病患者的组织损伤方面发挥着潜在的作用、9 我们旨在确定维生素 D 辅助治疗对肺结核患者预后的作用,并评估维生素 D 给药对维生素 D 缺乏性肺结核患者的白细胞计数差异、红细胞沉降率、血清腺苷脱氨酶、血清 C 反应蛋白、血氧饱和度(SpO2)和体重的影响。新确诊的维生素 D 缺乏性肺结核患者被随机分配到干预组(接受标准抗结核治疗,同时辅助维生素 D3)和对照组(接受标准抗结核治疗,同时不辅助维生素 D3)。干预组共口服四剂维生素 D3(每剂 2.5 毫克(100000 IU))。第一剂在开始抗结核治疗后 7 天内服用,第二、三、四剂分别在 2、4 和 6 周后服用。入组时,我们测量了所有基线特征。在随访期间,我们分别在 2、4、6、8 和 12 周测量了研究变量并监测了不良事件。我们的安全参数是血清校正钙水平,以评估高钙血症的风险。研究结果表明,与对照组相比,干预组的中性粒细胞计数在每个测量时间点的下降都具有统计学意义,影响程度较小;淋巴细胞计数在第 4、6 和 8 周的上升都具有统计学意义,影响程度为小和中等。干预组的红细胞沉降率在 6 周和 8 周时的下降具有统计学意义,影响程度较小;干预组的血清腺苷脱氨酶和血清 C 反应蛋白在 4 周、6 周和 8 周时的下降具有统计学意义,影响程度中等。干预组与对照组相比,氧饱和度在 4 周时的增加具有统计学意义,但影响程度较小;干预组与对照组相比,体重的增加具有统计学意义,但影响程度较小。没有高钙血症病例的报告。结论我们的研究结果表明,辅助维生素 D3 有可能加速肺结核患者炎症反应的缓解并改善其临床疗效。试验注册本试验已在印度临床试验注册中心注册(http://ctri.nic.in)注册,CTRI编号为- CTRI/2021/11/037914。研究地点印度北方邦埃塔瓦(U.P.)塞法伊市北方邦医科大学呼吸内科一楼门诊部(OPD)和四楼住院病房27号房间。
{"title":"Effect of adjunct Vitamin D treatment in vitamin D deficient pulmonary tuberculosis patients: A randomized, double blind, active controlled clinical trial","authors":"Harish Chandra ,&nbsp;Adil Rahman ,&nbsp;Prashant Yadav ,&nbsp;Geeta Maurya ,&nbsp;Sushil Kumar Shukla","doi":"10.1016/j.ijtb.2023.04.026","DOIUrl":"10.1016/j.ijtb.2023.04.026","url":null,"abstract":"<div><h3>Background</h3><p><span>Since, Vitamin D [1α,25(OH)</span><sub>2</sub><span>D)] enhances antimicrobial activity of Innate immunity and modulate Adaptive immune responses, simultaneously, so it play a potential role for balanced immune activity against </span><span><em>Mycobacterium tuberculosis</em></span><span><span> and restricting tissue injuries within the TB patients.(Chun et al., 2011) 9 We aimed to determine the role of adjunct Vitamin D treatment on the outcome of </span>pulmonary tuberculosis<span> patients and evaluated the effect of Vitamin D administration on Differential Leucocyte Count, Erythrocyte Sedimentation Rate<span><span>, serum Adenosine deaminase, serum C- reactive protein, </span>Oxygen saturation (SpO2) and Body Weight in Vitamin D deficient pulmonary tuberculosis patients.</span></span></span></p></div><div><h3>Methods</h3><p><span><span>We conducted a prospective, interventional, randomized, double blind, parallel group, active controlled clinical trial. Newly diagnosed Vitamin D deficient pulmonary tuberculosis patients were randomly assigned to intervention group (received standard anti-tubercular treatment with adjunct Vitamin D3) and control group (received standard anti-tubercular treatment without adjunct Vitamin D3). Total four doses [each dose of 2.5 mg (100000 IU)] of </span>Vitamin D3 were given, orally. First dose was given within 7 days of starting anti-tubercular treatment and second, third, fourth dose were given at 2, 4 and 6 weeks respectively. At the time of enrollment, we measured all baseline characteristics. During follow-up, we measured the study variables and monitored adverse events at 2, 4, 6, 8 and 12 weeks. Our safety parameter was serum corrected calcium level to assess the risk of </span>hypercalcemia.</p></div><div><h3>Results</h3><p>Total 130 pulmonary TB patients, 65 patients in each group, were analyzed. Our study results showed that decrease in Neutrophil count was statistically significant with small effect sizes at every time point of measurement and increase in Lymphocyte count was statistically significant with small and moderate effect sizes at 4, 6 and 8 week for intervention group than for control group. Decrease in erythrocyte sedimentation rate was statistically significant with small effect sizes at 6 and 8 week, decrease in serum adenosine deaminase and serum C- reactive protein was statistically significant with moderate effect sizes at 4, 6 and 8 week for intervention group than for control group. Increase in Oxygen saturation was statistically significant at 4 week with small effect size and increase in body weight was statistically significant with small effect sizes for intervention group than for control group. No case of hypercalcemia was reported.</p></div><div><h3>Conclusion</h3><p>Our findings suggest a potential role of adjunctive Vitamin D3 to accelerate resolution of inflammatory responses and improvement in clinical outcomes of pulmonary TB patients.</p>","PeriodicalId":39346,"journal":{"name":"Indian Journal of Tuberculosis","volume":"71 2","pages":"Pages 170-178"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48028018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
India marching towards TB elimination: How far we are 印度朝着消除结核病迈进:我们走了多远
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.ijtb.2023.06.019
Payel Roy, Ambarish Das, Ashutosh Panda, Shivya T, A. Priyadarshani, Binod Kumar Patro

Tuberculosis continues to be the leading cause of death worldwide. India shares twenty five percent of total tuberculosis population. Programmatic approach to fight against tuberculosis started in this country in the form of National Tuberculosis Program (NTP). In due course of time India adopted many strategic changes in its fight against tuberculosis. The current program named National tuberculosis elimination program (NTEP) has been set up to eliminate TB by 2025. There are some challenges which India need to overcome to achieve its target five years ahead of the sustainable development goals. Insufficient budget, inadequate diagnostic facilities, under-reporting, low success rate, high dropout rate, social stigma are some of the major challenges in the path to achieve a TB elimination status. Besides that, all the backlogs demand for swift performance in identification, notification, and treatment of TB cases. India has all the potential to eliminate tuberculosis. Strengthening of health system, mainstreaming of private sectors, enhancing diagnostic facilities, inclusion of latest diagnostic techniques, addressing social hindrances, and advocacy for higher budget are some of the program strengthening measures, if followed properly, can take India towards a TB free status.

结核病仍然是全世界的主要死因。印度占结核病患者总数的百分之二十五。印度以国家结核病防治计划(NTP)的形式开始了结核病防治工作。随着时间的推移,印度在抗击结核病的过程中采取了许多战略变革。目前的计划名为 "国家消除结核病计划"(NTEP),旨在到 2025 年消除结核病。为提前五年实现可持续发展目标,印度需要克服一些挑战。预算不足、诊断设施不足、报告不足、成功率低、辍学率高、社会污名化是实现消除结核病目标道路上的一些主要挑战。除此之外,所有这些积压的问题都要求在结核病例的识别、通报和治疗方面迅速取得成效。印度具备消除结核病的所有潜力。加强卫生系统、将私营部门纳入主流、加强诊断设施、采用最新诊断技术、解决社会障碍以及争取更多预算,这些都是加强计划的措施,如果执行得当,就能将印度带向无结核病国家。
{"title":"India marching towards TB elimination: How far we are","authors":"Payel Roy,&nbsp;Ambarish Das,&nbsp;Ashutosh Panda,&nbsp;Shivya T,&nbsp;A. Priyadarshani,&nbsp;Binod Kumar Patro","doi":"10.1016/j.ijtb.2023.06.019","DOIUrl":"10.1016/j.ijtb.2023.06.019","url":null,"abstract":"<div><p><span>Tuberculosis continues to be the leading cause of death worldwide. India shares twenty five percent of total tuberculosis population. Programmatic approach to fight against tuberculosis started in this country in the form of National Tuberculosis Program (NTP). In due course of time India adopted many strategic changes in its fight against tuberculosis. The current program named National tuberculosis elimination program (NTEP) has been set up to eliminate TB by 2025. There are some challenges which India need to overcome to achieve its target five years ahead of the sustainable development goals. Insufficient budget, inadequate diagnostic facilities, under-reporting, low success rate, high dropout rate, social stigma<span> are some of the major challenges in the path to achieve a TB elimination status. Besides that, all the backlogs demand for swift performance in identification, notification, and treatment of TB cases. India has all the potential to eliminate tuberculosis. Strengthening of </span></span>health system, mainstreaming of private sectors, enhancing diagnostic facilities, inclusion of latest diagnostic techniques, addressing social hindrances, and advocacy for higher budget are some of the program strengthening measures, if followed properly, can take India towards a TB free status.</p></div>","PeriodicalId":39346,"journal":{"name":"Indian Journal of Tuberculosis","volume":"71 2","pages":"Pages 213-218"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41259368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“The Validation of a Multidimensional Tool to test knowledge, barriers, and the challenges in screening for Tuberculosis among patients with Diabetes Mellitus” "测试糖尿病患者肺结核筛查知识、障碍和挑战的多维工具的验证
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.ijtb.2024.04.007
Monisha Mary.P, A. Jacob, Avinash Shetty
{"title":"“The Validation of a Multidimensional Tool to test knowledge, barriers, and the challenges in screening for Tuberculosis among patients with Diabetes Mellitus”","authors":"Monisha Mary.P, A. Jacob, Avinash Shetty","doi":"10.1016/j.ijtb.2024.04.007","DOIUrl":"https://doi.org/10.1016/j.ijtb.2024.04.007","url":null,"abstract":"","PeriodicalId":39346,"journal":{"name":"Indian Journal of Tuberculosis","volume":"73 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140784592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“Harm reduction approach for tuberculosis and substance use disorders: A review of approaches and implications in the Indian context” "减少结核病和药物使用失调危害的方法:审查印度的方法和影响"
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.ijtb.2023.09.013
Udit Kumar Panda , Soumya Swaroop Sahoo , Swayanka Samantaray

There are limitations to traditional treatment approaches in addressing the needs of individuals with dual comorbidity of TB and SUD. The concept of harm reduction as a distinct approach to addressing substance use, focusing on minimising the negative consequences associated with it rather than advocating for complete abstinence. Different harm reduction strategies, such as opioid substitution therapy, needle and syringe programmes, testing for viral infections etc. have been effectively employed for SUDs in past. Similarly, TB risk minimization approaches like improving housing and nutrition and focused testing strategies are considered as harm reduction strategies for TB management. The relationship between tuberculosis (TB) and substance use disorders (SUDs) involves a complex interplay of biopsychosocial factors. It is crucial to prioritise integrated and closely monitored care in order to address the treatment challenges and potential drug interactions that may arise. In light of the acknowledged challenges like limited awareness, infrastructure, drug resistance, and stigma, it is imperative to explore potential avenues for the implementation of harm reduction strategies targeting individuals with comorbid TB and SUD in India. Potential strategies for addressing the issue includes a range of measures, such as augmenting investments in healthcare, integrating policies, tackling social determinants, and establishing shared platforms for psychosocial rehabilitation.

传统治疗方法在满足结核病和药物滥用双重合并症患者的需求方面存在局限性。减少危害的概念是解决药物使用问题的一种独特方法,其重点是尽量减少与药物使用相关的负面影响,而不是提倡完全戒断。不同的减低危害策略,如阿片类药物替代疗法、针头和针筒计划、病毒感染检测等,在过去已被有效地用于治疗药物滥用。同样,结核病风险最小化方法,如改善住房和营养以及重点检测策略,也被视为结核病管理中的减少危害策略。结核病(TB)与药物使用障碍(SUDs)之间的关系涉及复杂的生物-心理-社会因素的相互作用。为了应对治疗挑战和可能出现的潜在药物相互作用,优先考虑综合和密切监测护理至关重要。鉴于公认的挑战,如有限的意识、基础设施、耐药性和污名化,当务之急是探索针对印度结核病和药物滥用并发症患者实施减少伤害战略的潜在途径。解决这一问题的潜在战略包括一系列措施,如增加医疗保健投资、整合政策、解决社会决定因素以及建立社会心理康复共享平台。
{"title":"“Harm reduction approach for tuberculosis and substance use disorders: A review of approaches and implications in the Indian context”","authors":"Udit Kumar Panda ,&nbsp;Soumya Swaroop Sahoo ,&nbsp;Swayanka Samantaray","doi":"10.1016/j.ijtb.2023.09.013","DOIUrl":"10.1016/j.ijtb.2023.09.013","url":null,"abstract":"<div><p><span><span>There are limitations to traditional treatment approaches in addressing the needs of individuals with dual comorbidity of TB and SUD. The concept of harm reduction as a distinct approach to addressing substance use, focusing on minimising the negative consequences associated with it rather than advocating for complete abstinence. Different harm reduction strategies, such as </span>opioid substitution therapy, needle and syringe programmes, testing for viral infections etc. have been effectively employed for SUDs in past. Similarly, TB risk minimization approaches like improving housing and nutrition and focused testing strategies are considered as harm reduction strategies for TB management. The relationship between tuberculosis (TB) and substance use disorders (SUDs) involves a complex interplay of biopsychosocial factors. It is crucial to prioritise integrated and closely monitored care in order to address the treatment challenges and potential drug interactions that may arise. In light of the acknowledged challenges like limited awareness, infrastructure, drug resistance, and stigma, it is imperative to explore potential avenues for the implementation of harm reduction strategies targeting individuals with comorbid TB and SUD in India. Potential strategies for addressing the issue includes a range of measures, such as augmenting investments in healthcare, integrating policies, tackling </span>social determinants<span>, and establishing shared platforms for psychosocial rehabilitation.</span></p></div>","PeriodicalId":39346,"journal":{"name":"Indian Journal of Tuberculosis","volume":"71 2","pages":"Pages 219-224"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135588943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Availability, utilization and challenges for implementation of Nikshay Mitra scheme in Mandya district of Karnataka: A cross-sectional mixed method concurrent evaluation study 在卡纳塔克邦曼迪亚县实施 Nikshay Mitra 计划的可得性、利用率和挑战:一项横截面混合方法并行评估研究
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.ijtb.2024.03.014
Hugara Siddalingappa, Neha Dsouza, H. B R, Navyashree V, Nenavath Jayaprakash Manya, N. Babu. M, Nisarga Priyadarshini G C, Nisarga S, Majinas T, Malavika M. Thampi, Manjunath B. Murabatti, Meghana D S, Mohammed Alauddin
{"title":"Availability, utilization and challenges for implementation of Nikshay Mitra scheme in Mandya district of Karnataka: A cross-sectional mixed method concurrent evaluation study","authors":"Hugara Siddalingappa, Neha Dsouza, H. B R, Navyashree V, Nenavath Jayaprakash Manya, N. Babu. M, Nisarga Priyadarshini G C, Nisarga S, Majinas T, Malavika M. Thampi, Manjunath B. Murabatti, Meghana D S, Mohammed Alauddin","doi":"10.1016/j.ijtb.2024.03.014","DOIUrl":"https://doi.org/10.1016/j.ijtb.2024.03.014","url":null,"abstract":"","PeriodicalId":39346,"journal":{"name":"Indian Journal of Tuberculosis","volume":"80 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140765838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of tuberculosis in homes for the aged and orphanages of a district in Kerala, India 印度喀拉拉邦某地区养老院和孤儿院的结核病流行情况
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.ijtb.2023.04.013
Zinia T. Nujum , Sindhu S , P.S. Rakesh , Remya G , Anuja U

Background

India accounts for one fourth of the TB burden globally. One of the objectives of the National Strategic Plan is to achieve 90% notification rate of all TB cases. Screening of high risk groups is one of the important components towards achieving this objective. Inmates of homes for the aged and orphanages are at higher risk of having TB infection and disease. Hence this study was conducted with the objective of identifying the prevalence of TB among inmates of homes for the aged and orphanages.

Methods

A cross sectional study was done in homes for the aged and orphanages of Kollam district of Kerala in India. Sample size was estimated as 466. Cluster sampling using probability proportionate to size was used. There were 32 homes for the aged, from which 5 were selected. Out of 43 orphanages 8 were selected. Inmates were screened using a questionnaire. Those with any of the symptoms suggestive of TB were examined by a pulmonologist in a camp conducted at the institute. Those who needed further evaluation were brought to Government Medical College, Kollam/other nearest government health setting. All those who were detected to be having tuberculosis, were guided and given the care as per the NTEP treatment protocol. Permission was taken from the Collector of Kollam district. Informed written consent from the study subjects/legally accepted representative and assent were taken.

Results

533 inmates were assessed from homes for the aged. The mean age was 56.70 (SD - 17.40). Five new TB patients were identified during the study. Of this three patients had extra-pulmonary and two were pulmonary TB. Eight patients were receiving treatment for TB at the time of study already, seven of which were pulmonary and one was extra-pulmonary. So the prevalence of TB in homes for the aged was 13/533 ie 2.43% (95%CI – 1.36 to 4.03%) or 2430/lakh. A higher percentage of inmates with tuberculosis were females, stayed in dormitory, had only primary education, had history of contact with TB and were undernourished compared to inmates without tuberculosis.

We screened 478 children in orphanages of Kollam district. There were no children less than 5 years. Most of the children were in the age group of 10–15 years (62.1%). Nine children (1.9%) had history of contact with TB. One child had a previous history of TB. There was only one child who was suspected to have Tuberculosis, She was evaluated by a pediatrician and Tuberculosis was ruled out.

Conclusion

The prevalence of TB in inmates of homes for the aged is much higher than the general population. This highlights the need for a more active case detection in such institutions, especially in the context of the country marching towards TB elimination. The absence of tuberculosis among children in orphanages is a positive indicator that the community is moving in

背景印度的结核病负担占全球的四分之一。国家战略计划的目标之一是使所有肺结核病例的通报率达到 90%。对高危人群进行筛查是实现这一目标的重要组成部分之一。养老院和孤儿院的囚犯感染结核病的风险较高。因此,本研究旨在确定老年之家和孤儿院的住院者中结核病的流行情况。方法 在印度喀拉拉邦科拉姆地区的老年之家和孤儿院进行了一项横断面研究。样本量估计为 466 个。采用与规模成比例的概率分组抽样法。共有 32 家养老院,其中 5 家被选中。在 43 家孤儿院中抽取了 8 家。使用调查问卷对囚犯进行筛查。那些有任何肺结核症状的人都会在研究所举办的营会上接受肺科医生的检查。需要进一步评估的人被送往科拉姆政府医学院/其他最近的政府医疗机构。所有被检测出患有肺结核的人都按照 NTEP 治疗方案接受了指导和治疗。研究获得了科勒姆县县长的许可。获得了研究对象/法定代表人的知情书面同意。平均年龄为 56.70 岁(SD - 17.40)。研究期间发现了五名新的肺结核患者。其中 3 名患者为肺外结核,2 名患者为肺结核。研究期间,有 8 名患者正在接受结核病治疗,其中 7 人是肺结核,1 人是肺外结核。因此,安老院的结核病发病率为 13/533,即 2.43%(95%CI - 1.36 至 4.03%)或 2430/lakh。与未患肺结核的住院者相比,患肺结核的住院者中女性比例较高,她们住在宿舍里,只受过小学教育,有肺结核接触史,而且营养不良。其中没有 5 岁以下的儿童。大多数儿童的年龄在 10-15 岁之间(62.1%)。九名儿童(1.9%)有结核病接触史。一名儿童曾患肺结核。只有一名儿童被怀疑患有肺结核,儿科医生对她进行了评估,排除了肺结核的可能性。这凸显了在此类机构中进行更积极的病例检测的必要性,尤其是在我国正朝着消灭结核病的目标迈进的背景下。孤儿院儿童中未发现结核病是一个积极的指标,表明社会正朝着消除结核病的方向迈进。
{"title":"Prevalence of tuberculosis in homes for the aged and orphanages of a district in Kerala, India","authors":"Zinia T. Nujum ,&nbsp;Sindhu S ,&nbsp;P.S. Rakesh ,&nbsp;Remya G ,&nbsp;Anuja U","doi":"10.1016/j.ijtb.2023.04.013","DOIUrl":"10.1016/j.ijtb.2023.04.013","url":null,"abstract":"<div><h3>Background</h3><p>India accounts for one fourth of the TB burden globally. One of the objectives of the National Strategic Plan is to achieve 90% notification rate of all TB cases. Screening of high risk groups is one of the important components towards achieving this objective. Inmates of homes for the aged and orphanages are at higher risk of having TB infection and disease. Hence this study was conducted with the objective of identifying the prevalence of TB among inmates of homes for the aged and orphanages.</p></div><div><h3>Methods</h3><p><span>A cross sectional study was done in homes for the aged and orphanages of Kollam district of Kerala in India. Sample size was estimated as 466. Cluster sampling using probability proportionate to size was used. There were 32 homes for the aged</span><strong>,</strong><span> from which 5 were selected. Out of 43 orphanages 8 were selected. Inmates were screened using a questionnaire. Those with any of the symptoms<span> suggestive of TB were examined by a pulmonologist in a camp conducted at the institute. Those who needed further evaluation were brought to Government Medical College, Kollam/other nearest government health setting. All those who were detected to be having tuberculosis, were guided and given the care as per the NTEP treatment protocol. Permission was taken from the Collector of Kollam district. Informed written consent from the study subjects/legally accepted representative and assent were taken.</span></span></p></div><div><h3>Results</h3><p>533 inmates were assessed from homes for the aged. The mean age was 56.70 (SD - 17.40). Five new TB patients were identified during the study. Of this three patients had extra-pulmonary and two were pulmonary TB. Eight patients were receiving treatment for TB at the time of study already, seven of which were pulmonary and one was extra-pulmonary. So the prevalence of TB in homes for the aged was 13/533 ie 2.43% (95%CI – 1.36 to 4.03%) or 2430/lakh. A higher percentage of inmates with tuberculosis were females, stayed in dormitory, had only primary education, had history of contact with TB and were undernourished compared to inmates without tuberculosis.</p><p>We screened 478 children in orphanages of Kollam district. There were no children less than 5 years. Most of the children were in the age group of 10–15 years (62.1%). Nine children (1.9%) had history of contact with TB. One child had a previous history of TB. There was only one child who was suspected to have Tuberculosis, She was evaluated by a pediatrician and Tuberculosis was ruled out.</p></div><div><h3>Conclusion</h3><p>The prevalence of TB in inmates of homes for the aged is much higher than the general population. This highlights the need for a more active case detection in such institutions, especially in the context of the country marching towards TB elimination. The absence of tuberculosis among children in orphanages is a positive indicator that the community is moving in ","PeriodicalId":39346,"journal":{"name":"Indian Journal of Tuberculosis","volume":"71 2","pages":"Pages 130-136"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45897059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic accuracy of tests for tuberculous pericarditis: A network meta-analysis 结核性心包炎检测的诊断准确性:网络荟萃分析
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.ijtb.2023.05.013
Alina Pervez , S. Umar Hasan , Mohammad Hamza , Sohaib Asghar , Muhammad Husnain Qaiser , Sana Zaidi , Isra Mustansar

Tuberculous pericarditis (TBP) is a relatively uncommon but potentially fatal extrapulmonary manifestation of tuberculosis. Despite its severity, there is no universally accepted gold standard diagnostic test for TBP currently. The objective of this study is to compare the diagnostic accuracy of the most commonly used tests in terms of specificity, sensitivity, negative predictive value (NPV), and positive predictive value (PPV), and provide a summary of their diagnostic accuracies. A comprehensive literature review was performed using Scopus, MEDLINE, and Cochrane central register of controlled trials, encompassing studies published from start to April 2022. Studies that compared Interferon Gamma Release Assay (IGRA), Xpert MTB/RIF, Adenosine Deaminase levels (ADA), and Smear Microscopy (SM) were included in the analysis. Bayesian random-effects model was used for statistical analysis and mean and standard deviation (SD) with 95% confidence intervals were calculated using the absolute risk (AR) and odds ratio (OR). Rank probability and heterogeneity were determined using risk difference and Cochran Q test, respectively. Sensitivity and specificity were evaluated using true negative, true positive, false positive, and false negative rates. Area under the receiver operating characteristic (AUROC) was calculated for mean and standard error. A total of seven studies comprising 16 arms and 618 patients were included in the analysis. IGRA exhibited the highest mean (SD) sensitivity of 0.934 (0.049), with a high rank probability of 87.5% for being the best diagnostic test, and the AUROC was found to be 94.8 (0.36). On the other hand, SM demonstrated the highest mean (SD) specificity of 0.999 (0.011), with a rank probability of 99.5%, but a leave-one-out analysis excluding SM studies revealed that Xpert MTB/RIF ranked highest for specificity, with a mean (SD) of 0.962 (0.064). The diagnostic tests compared in our study exhibited similar high NPV, while ADA was found to have the lowest PPV among the evaluated methods. Further research, including comparative studies, should be conducted using a standardized cutoff value for both ADA levels and IGRA to mitigate the risk of threshold effect and minimize bias and heterogeneity in data analysis.

结核性心包炎(TBP)是一种相对少见但可能致命的结核病肺外表现。尽管结核性心包炎十分严重,但目前还没有公认的诊断结核性心包炎的金标准检测方法。本研究旨在从特异性、灵敏度、阴性预测值(NPV)和阳性预测值(PPV)等方面比较最常用检测方法的诊断准确性,并对其诊断准确性进行总结。我们使用 Scopus、MEDLINE 和 Cochrane 对照试验中央登记册进行了全面的文献综述,包括从开始到 2022 年 4 月发表的研究。比较干扰素γ释放试验(IGRA)、Xpert MTB/RIF、腺苷脱氨酶水平(ADA)和涂片显微镜检查(SM)的研究均被纳入分析范围。统计分析采用贝叶斯随机效应模型,使用绝对风险(AR)和几率比(OR)计算平均值和标准差(SD)以及 95% 的置信区间。等级概率和异质性分别通过风险差异和 Cochran Q 检验来确定。使用真阴性率、真阳性率、假阳性率和假阴性率评估灵敏度和特异性。受试者操作特征下面积(AUROC)的计算采用平均值和标准误差。共有 7 项研究纳入分析,包括 16 个研究臂和 618 名患者。IGRA 的平均(标准差)灵敏度最高,为 0.934 (0.049),成为最佳诊断测试的概率高达 87.5%,AUROC 为 94.8 (0.36)。另一方面,SM 的特异性平均值(SD)最高,为 0.999 (0.011),排名概率为 99.5%,但在排除 SM 研究后进行的剔除分析显示,Xpert MTB/RIF 的特异性排名最高,平均值(SD)为 0.962 (0.064)。我们的研究中比较的诊断测试都表现出类似的高 NPV,而 ADA 的 PPV 在所有评估方法中最低。进一步的研究(包括比较研究)应使用 ADA 水平和 IGRA 的标准化临界值,以降低阈值效应的风险,并最大限度地减少数据分析中的偏差和异质性。
{"title":"Diagnostic accuracy of tests for tuberculous pericarditis: A network meta-analysis","authors":"Alina Pervez ,&nbsp;S. Umar Hasan ,&nbsp;Mohammad Hamza ,&nbsp;Sohaib Asghar ,&nbsp;Muhammad Husnain Qaiser ,&nbsp;Sana Zaidi ,&nbsp;Isra Mustansar","doi":"10.1016/j.ijtb.2023.05.013","DOIUrl":"10.1016/j.ijtb.2023.05.013","url":null,"abstract":"<div><p><span>Tuberculous pericarditis (TBP) is a relatively uncommon but potentially fatal extrapulmonary manifestation of tuberculosis. Despite its severity, there is no universally accepted gold standard diagnostic test for TBP currently. The objective of this study is to compare the diagnostic accuracy of the most commonly used tests in terms of specificity, sensitivity, negative predictive value (NPV), and positive predictive value (PPV), and provide a summary of their diagnostic accuracies. A comprehensive literature review was performed using Scopus, MEDLINE, and Cochrane central register of controlled trials, encompassing studies published from start to April 2022. Studies that compared </span>Interferon Gamma Release Assay<span><span> (IGRA), Xpert MTB/RIF, Adenosine Deaminase levels (ADA), and Smear Microscopy (SM) were included in the analysis. Bayesian random-effects model was used for statistical analysis and mean and standard deviation (SD) with 95% confidence intervals were calculated using the absolute risk (AR) and odds ratio (OR). Rank probability and heterogeneity were determined using risk difference and Cochran Q test, respectively. Sensitivity and specificity were evaluated using true negative, true positive, false positive, and </span>false negative rates. Area under the receiver operating characteristic (AUROC) was calculated for mean and standard error. A total of seven studies comprising 16 arms and 618 patients were included in the analysis. IGRA exhibited the highest mean (SD) sensitivity of 0.934 (0.049), with a high rank probability of 87.5% for being the best diagnostic test, and the AUROC was found to be 94.8 (0.36). On the other hand, SM demonstrated the highest mean (SD) specificity of 0.999 (0.011), with a rank probability of 99.5%, but a leave-one-out analysis excluding SM studies revealed that Xpert MTB/RIF ranked highest for specificity, with a mean (SD) of 0.962 (0.064). The diagnostic tests compared in our study exhibited similar high NPV, while ADA was found to have the lowest PPV among the evaluated methods. Further research, including comparative studies, should be conducted using a standardized cutoff value for both ADA levels and IGRA to mitigate the risk of threshold effect and minimize bias and heterogeneity in data analysis.</span></p></div>","PeriodicalId":39346,"journal":{"name":"Indian Journal of Tuberculosis","volume":"71 2","pages":"Pages 185-194"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46943650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthcare schemes to overcome financial toxicity of COVID-19: A retrospective single center study 克服 COVID-19 经济毒性的医疗保健方案:单中心回顾性研究
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.ijtb.2024.04.010
Anjana Madhusoodanan, R. K. Chaudhary, Shivakumar Hiremath, U. Mateti, Shraddha Shetty
{"title":"Healthcare schemes to overcome financial toxicity of COVID-19: A retrospective single center study","authors":"Anjana Madhusoodanan, R. K. Chaudhary, Shivakumar Hiremath, U. Mateti, Shraddha Shetty","doi":"10.1016/j.ijtb.2024.04.010","DOIUrl":"https://doi.org/10.1016/j.ijtb.2024.04.010","url":null,"abstract":"","PeriodicalId":39346,"journal":{"name":"Indian Journal of Tuberculosis","volume":"23 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140772688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing Diagnostic Accuracy: Xpert MTB/RIF Ultra vs. Xpert MTB/RIF for diagnosis of Pulmonary Tuberculosis 比较诊断准确性:Xpert MTB/RIF Ultra 与 Xpert MTB/RIF 在诊断肺结核方面的准确性比较
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.ijtb.2024.04.009
S. Sethi, Shelly Sharma, S. Dhatwalia, Sumedha Sharma, Ashutosh N. Aggarwal, Rakesh Yadav
{"title":"Comparing Diagnostic Accuracy: Xpert MTB/RIF Ultra vs. Xpert MTB/RIF for diagnosis of Pulmonary Tuberculosis","authors":"S. Sethi, Shelly Sharma, S. Dhatwalia, Sumedha Sharma, Ashutosh N. Aggarwal, Rakesh Yadav","doi":"10.1016/j.ijtb.2024.04.009","DOIUrl":"https://doi.org/10.1016/j.ijtb.2024.04.009","url":null,"abstract":"","PeriodicalId":39346,"journal":{"name":"Indian Journal of Tuberculosis","volume":"151 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140777956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A systematic review on cost-effectiveness of diagnostic methods and treatments for tuberculosis in India 关于印度结核病诊断方法和治疗成本效益的系统审查
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.ijtb.2024.04.006
Mohan Balakrishnan, R. Varadharajan, G. Gajendran
{"title":"A systematic review on cost-effectiveness of diagnostic methods and treatments for tuberculosis in India","authors":"Mohan Balakrishnan, R. Varadharajan, G. Gajendran","doi":"10.1016/j.ijtb.2024.04.006","DOIUrl":"https://doi.org/10.1016/j.ijtb.2024.04.006","url":null,"abstract":"","PeriodicalId":39346,"journal":{"name":"Indian Journal of Tuberculosis","volume":"186 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140784424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Tuberculosis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1